Spinal Cord Dose Tolerance to Stereotactic Body Radiation Therapy.


Journal

International journal of radiation oncology, biology, physics
ISSN: 1879-355X
Titre abrégé: Int J Radiat Oncol Biol Phys
Pays: United States
ID NLM: 7603616

Informations de publication

Date de publication:
01 05 2021
Historique:
received: 22 09 2019
revised: 22 09 2019
accepted: 25 09 2019
pubmed: 14 10 2019
medline: 5 8 2021
entrez: 14 10 2019
Statut: ppublish

Résumé

Spinal cord tolerance data for stereotactic body radiation therapy (SBRT) were extracted from published reports, reviewed, and modelled. For de novo SBRT delivered in 1 to 5 fractions, the following spinal cord point maximum doses (D

Identifiants

pubmed: 31606528
pii: S0360-3016(19)33862-3
doi: 10.1016/j.ijrobp.2019.09.038
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

124-136

Informations de copyright

Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Auteurs

Arjun Sahgal (A)

Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada. Electronic address: arjun.sahgal@sunnybrook.ca.

Joe H Chang (JH)

Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.

Lijun Ma (L)

Department of Radiation Oncology, University of California, San Francisco, San Francisco, California.

Lawrence B Marks (LB)

Department of Radiation Oncology, University of North Carolina, Chapel Hill, North Carolina.

Michael T Milano (MT)

Department of Radiation Oncology, University of Rochester, Rochester, New York.

Paul Medin (P)

Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, Texas.

Andrzej Niemierko (A)

Department of Radiation Oncology, Harvard University, Boston, Massachusetts.

Scott G Soltys (SG)

Department of Radiation Oncology, Stanford University Medical Center, Stanford, California.

Wolfgang A Tomé (WA)

Department of Radiation Oncology, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, New York.

C Shun Wong (CS)

Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.

Ellen Yorke (E)

Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York.

Jimm Grimm (J)

Department of Radiation Oncology, Geisinger Health System, Danville, Pennsylvania.

Andrew Jackson (A)

Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH